The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).
 
Brandon George Smaglo
Speakers' Bureau - Sirtex Medical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Marker Therapeutics
 
Benjamin Leon Musher
Consulting or Advisory Role - Celgene; Exelixis
Speakers' Bureau - Ipsen
Research Funding - Lokon Pharma
 
Spyridoula Vasileiou
No Relationships to Disclose
 
Manik Kuvalekar
Consulting or Advisory Role - Allovir
 
Ayumi Watanabe
Consulting or Advisory Role - Allovir
 
Catherine Robertson
Consulting or Advisory Role - Allovir
Travel, Accommodations, Expenses - TESSA Therapeutics
 
Tao Wang
No Relationships to Disclose
 
Monica Francois
No Relationships to Disclose
 
Carlos Almeida Ramos
Consulting or Advisory Role - Novartis
Research Funding - Tessa Therapeutics
 
LaQuisa Hill
Consulting or Advisory Role - Incyte
 
George Van Buren
Travel, Accommodations, Expenses - Intuitive Surgical
 
William Fisher
Travel, Accommodations, Expenses - Intuitive Surgical
 
Tannaz Armaghany
Speakers' Bureau - Lexicon
Travel, Accommodations, Expenses - Lexicon
 
Yvonne Sada
No Relationships to Disclose
 
Juan Fernando Vera Valdes
Employment - Marker Therapeutics
Leadership - AlloVir; Marker Therapeutics
Stock and Other Ownership Interests - AlloVir; Marker Therapeutics
Honoraria - AlloVir; Marker Therapeutics
Consulting or Advisory Role - AlloVir; Marker Therapeutics
Speakers' Bureau - Marker Therapeutics
Research Funding - AlloVir; Marker Therapeutics
Patents, Royalties, Other Intellectual Property - AlloVir; Marker Therapeutics
Travel, Accommodations, Expenses - AlloVir; Marker Therapeutics
 
Bambi Grilley
Employment - QB Regulatory Consulting
Leadership - QB Regulatory Consulting
Stock and Other Ownership Interests - AlloVir
Consulting or Advisory Role - QB Regulatory Consulting
Travel, Accommodations, Expenses - Tessa Therapeutics
 
Adrian P Gee
No Relationships to Disclose
 
Helen E. Heslop
Stock and Other Ownership Interests - Allovir; Marker Therapeutics
Consulting or Advisory Role - Gilead Sciences; Kiadis Pharma; Marker Therapeutics; Novartis; PACT Pharma; Tessa Therapeutics
Research Funding - Cell Medica (Inst); Tessa Therapeutics (Inst)
 
Premal D. Lulla
Stock and Other Ownership Interests - Johnson & Johnson (I)
Research Funding - Tessa Therapeutics
 
Ann M. Leen
Stock and Other Ownership Interests - Allovir; Marker Therapeutics
Consulting or Advisory Role - Allovir; Marker Therapeutics
Patents, Royalties, Other Intellectual Property - I have patents and pending patents in the field of cell therapy and i have received royalty payments
Travel, Accommodations, Expenses - Allovir; Marker Therapeutics